Russell Investments Group, Ltd. Applied Genetic Technologies Corp Transaction History

Russell Investments Group, Ltd.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$1.87 - $2.91 $77,077 - $119,944	-41,218 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$3.62 - $5.23 $15,015 - $21,694	-4,148 Reduced 9.14%	41,218 $160,000
Q1 2021 May 10, 2021	SELL	$3.94 - $8.19 $47,910 - $99,590	-12,160 Reduced 21.14%	45,366 $229,000
Q4 2020 Feb 08, 2021	SELL	$3.99 - $5.7 $404,677 - $578,111	-101,423 Reduced 63.81%	57,526 $234,000
Q3 2020 Nov 09, 2020	BUY	$4.38 - $6.43 $426,248 - $625,748	97,317 Added 157.9%	158,949 $771,000
Q2 2020 Aug 05, 2020	SELL	$3.0 - $6.9 $791,601 - $1.82 Million	-263,867 Reduced 81.07%	61,632 $340,000
Q1 2020 May 06, 2020	BUY	$2.36 - $9.86 $578,686 - $2.42 Million	245,206 Added 305.39%	325,499 $1.07 Million
Q4 2019 Jan 29, 2020	BUY	$2.69 - $4.92 $94,273 - $172,426	35,046 Added 77.45%	80,293 $358,000
Q2 2019 Aug 09, 2019	BUY	$3.6 - $4.78 $4,680 - $6,214	1,300 Added 2.96%	45,247 $170,000
Q1 2019 May 13, 2019	SELL	$2.62 - $4.44 $15,358 - $26,027	-5,862 Reduced 11.77%	43,947 $183,000
Q4 2018 Feb 11, 2019	SELL	$2.28 - $7.15 $14,402 - $45,166	-6,317 Reduced 11.26%	49,809 $126,000
Q3 2018 Oct 26, 2018	SELL	$3.85 - $7.35 $6,906 - $13,185	-1,794 Reduced 3.1%	56,126 $412,000
Q2 2018 Aug 08, 2018	SELL	$3.7 - $5.65 $9,150 - $13,972	-2,473 Reduced 4.09%	57,920 $220,000
Q1 2018 May 11, 2018	SELL	$3.65 - $5.2 $53,947 - $76,856	-14,780 Reduced 19.66%	60,393 $233,000
Q4 2017 Feb 06, 2018	SELL	$3.4 - $4.15 $1,499 - $1,830	-441 Reduced 0.58%	75,173 $276,000
Q3 2017 Nov 07, 2017	BUY	$3.55 - $5.25 $268,429 - $396,973	75,614	75,614 $298,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.